Go Pro

Great Lakes Advisors LLC Acquires Shares of 73,817 Proto Labs, Inc. $PRLB

Proto Labs logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Great Lakes Advisors LLC acquired 73,817 Proto Labs shares worth approximately $6.7 million, representing about 0.31% of the company. Institutional investors collectively own 84.54% of PRLB.
  • Analyst sentiment remains favorable: Proto Labs has an average “Buy” rating and an average price target of $89, with several firms recently raising their ratings or targets.
  • Proto Labs exceeded quarterly expectations, reporting $0.60 in EPS versus $0.53 expected and $149.34 million in revenue versus $144.53 million expected; revenue increased 10.5% year over year.
  • MarketBeat previews top five stocks to own in September.

Great Lakes Advisors LLC bought a new position in Proto Labs, Inc. (NYSE:PRLB - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 73,817 shares of the industrial products company's stock, valued at approximately $6,698,000. Great Lakes Advisors LLC owned approximately 0.31% of Proto Labs as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in PRLB. Group One Trading LLC purchased a new position in Proto Labs in the 4th quarter worth approximately $25,000. NewEdge Advisors LLC lifted its position in Proto Labs by 7,380.0% in the 1st quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company's stock valued at $26,000 after acquiring an additional 738 shares in the last quarter. NBC Securities Inc. purchased a new stake in Proto Labs during the 4th quarter valued at $46,000. USA Financial Formulas purchased a new stake in Proto Labs during the 1st quarter valued at $52,000. Finally, Modus Advisors LLC bought a new stake in shares of Proto Labs in the 4th quarter worth $57,000. Hedge funds and other institutional investors own 84.54% of the company's stock.

Insider Activity at Proto Labs

In other news, Director Sven Wehrwein sold 2,000 shares of the company's stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $77.28, for a total transaction of $154,560.00. Following the completion of the sale, the director owned 32,505 shares of the company's stock, valued at $2,511,986.40. This represents a 5.80% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.30% of the stock is owned by insiders.

Analyst Ratings Changes

PRLB has been the topic of a number of research analyst reports. Benchmark upped their price target on Proto Labs from $70.00 to $91.00 and gave the company a "buy" rating in a report on Thursday, July 2nd. Wall Street Zen downgraded Proto Labs from a "strong-buy" rating to a "buy" rating in a report on Saturday, July 18th. Weiss Ratings lowered Proto Labs from a "buy (b)" rating to a "buy (b-)" rating in a research report on Tuesday. Needham & Company LLC upgraded shares of Proto Labs from a "hold" rating to a "buy" rating and set a $87.00 target price on the stock in a research note on Monday, August 3rd. Finally, Zacks Research raised shares of Proto Labs from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 6th. One investment analyst has rated the stock with a Strong Buy rating and three have issued a Buy rating to the company's stock. Based on data from MarketBeat.com, Proto Labs has an average rating of "Buy" and an average price target of $89.00.

Check Out Our Latest Research Report on PRLB

Proto Labs Price Performance

NYSE PRLB opened at $82.11 on Thursday. Proto Labs, Inc. has a 1-year low of $45.10 and a 1-year high of $93.00. The stock has a market capitalization of $1.96 billion, a price-to-earnings ratio of 65.69 and a beta of 1.40. The business's fifty day moving average price is $80.53 and its 200-day moving average price is $69.94.

Proto Labs (NYSE:PRLB - Get Free Report) last posted its quarterly earnings data on Friday, July 31st. The industrial products company reported $0.60 EPS for the quarter, beating analysts' consensus estimates of $0.53 by $0.07. The company had revenue of $149.34 million during the quarter, compared to analysts' expectations of $144.53 million. Proto Labs had a return on equity of 4.80% and a net margin of 5.44%.Proto Labs's revenue for the quarter was up 10.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.41 earnings per share. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. Equities research analysts anticipate that Proto Labs, Inc. will post 1.46 EPS for the current year.

About Proto Labs

(Free Report)

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.

Featured Articles

Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLB - Free Report).

Institutional Ownership by Quarter for Proto Labs (NYSE:PRLB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Proto Labs Right Now?

Before you consider Proto Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.

While Proto Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines